Introduction
Rolandic epilepsy (RE) is the most common idiopathic, agespecific, epilepsy syndrome of childhood, with an estimated prevalence of 20-25% in school children with epilepsy.
1,2 RE is a sleep-related disorder, and attacks occur predominantly during sleep. Seizures during waking hours are more likely to occur shortly after awakening. 3 In general, RE is associated with a favorable prognosis. Seizure frequency is usually low, and around 10% of cases has only one seizure (isolated seizure). 2 Accordingly, continuous treatment should be considered only in patients with frequent seizures and when the ictal events are disruptive to the patient or family. However, prognostic factors for seizure recurrence remain unclear. 4 Interictal epileptiform discharges on electroencephalogram (EEG) are regarded as correlated with persistent pathological neuronal discharges. 5 Early descriptions suggested that children with rolandic spikes might be at risk for minor behavioral disturbances or learning difficulties. 6 Atypical cases sometimes occur as a particular syndrome that shares features with other recognized entities or has an unexpected evolution. However, with regard to the frequency of paroxysmal EEG abnormalities and the correlation with cognitive deficits, the association of more frequent discharges or multifocal paroxysms with complicated evolution in RE is a debated subject. 1, 7, 8 In contrast, in our preliminary study, significant correlations were found between atypical clinical features and extended periods of high-frequency paroxysmal EEG abnormalities in these atypical cases. 9 In another study by Bakke et al., interictal EEG abnormalities were associated with behavioral problems. 10 Moreover, our recent research showed a significant correlation between spike frequency in the frontal region and behavioral problems. 11 Thus, there is continued debate about the importance of paroxysmal EEG abnormalities and their relationships with clinical manifestations such as seizure recurrence and behavioral problems. Clinical and EEG markers to predict seizure recurrence need to be identified. The purpose of the present study was to determine the EEG criteria related to seizure recurrence in children with RE.
Purpose: The prognosis of rolandic epilepsy (RE) is considered favorable. Since a moderate proportion of cases presents with isolated seizures, continuous treatment should be considered only for frequent seizures. Clinical and electroencephalogram (EEG) markers to predict seizure recurrence need to be identified. The purpose of this study was to identify EEG criteria related to seizure recurrence in RE. Methods: There were 10 children (aged 3-10 years; 6 males, 4 females) in the recurrence group and 12 (aged 4-7 years; 6 males, 6 females) in the isolated group. Occurrences of the number of spikes were scored, and the presence of rolandic discharges (RD) in the awake record was evaluated. All patients were evaluated longitudinally, clinically and by EEG, with repeated EEG recordings every 3 months. Clinical and EEG follow-up was performed for !4 years. Results: Seizure recurrence and extended periods of high-frequency paroxysmal EEG abnormalities (>6 months after onset) were significantly correlated (p < 0.001). Moreover, the appearance of RD in awake recordings tended to be more prevalent in the recurrence group than in the isolated group (odds ratio 4.714). Conclusion: In addition to RD in the awake record, a combination of spike rate and extended periods of high-frequency paroxysmal EEG abnormalities may predict seizure recurrence in RE.
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Method

Participants
A total of 22 patients with normal neurological examinations and brain magnetic resonance imaging (MRI) was followed-up. All children had experienced their index seizure between April 1, 2001 and March 31, 2006. Patients were referred to us from the pediatric departments of University of Yamanashi Hospital and its satellite hospitals. All children were suspected as having RE at the first evaluation. However, the clinical course for some patients diverged from those of others. Some patients demonstrated no seizure recurrence during the follow-up period. Therefore, patients were divided into two groups according to their clinical presentation ( Table 1 ). The recurrence group consisted of children who suffered from typical RE, and the isolated group consisted of children without seizure recurrence. All children in this study were enrolled within 1 week after the appearance of their first seizure. To be included in this study, children (onset of seizures ranging from 3 to 14 years of age) had to have normal neurologic and neuroradiologic examinations. The exclusion criteria were as follows: concomitant neurologic or psychiatric disorders, neurosurgical operation, neurologic medication other than anti-epileptic drugs (AEDs), combination therapy (two or more AEDs), and/or an IQ less than or equal to 70. Patients with Fragile X syndrome were also excluded.
The recurrence group
This group consisted of 10 children ranging in age from 3 to 10 years (mean age, 5.5 years; 6 males, 4 females). All patients demonstrated the typical EEG abnormalities of this condition with normal neurological examinations, and they fulfilled the following criteria of typical RE 2 : (1) nocturnal partial seizures associated with centrotemporal spikes on EEG; (2) onset of seizures ranging from 3 to 14 years of age; (3) normal routine laboratory examination and normal results on screening for metabolic diseases (blood gas, lactate, pyruvate, and amino acid analyses); (4) normal brain MRI; and (5) absence of other types of unprovoked seizures. All patients were treated with antiepileptic drugs such as carbamazepine (CBZ) after their third seizures (2-6 months after seizure onset). All participants began therapy with CBZ, and one participant was switched to sodium valproate (VPA) because of a CBZ-related skin rash. Accordingly, nine children were treated by CBZ (mean dose, 6.3 mg/kg/day; mean trough concentration, 4.2 mg/mL) and one was treated by VPA (dose, 11.4 mg/kg/day; trough concentration, 48.8 mg/mL). The start of therapy was not related to deterioration in the EEG.
The isolated group
This group consisted of 12 children ranging in age from 4 to 7 years (mean age, 5.3 years; 6 males, 6 females). All patients fulfilled the above-mentioned criteria for RE. Accordingly, it was initially impossible to differentiate these patients from those in the recurrence group. None were given any treatment such as AEDs. All patients had no seizure recurrence.
Assessment of interictal EEG abnormalities
Assessment of interictal EEG abnormalities has been described in our previous report. 9 A brief outline of the assessment is provided. The EEGs were recorded without sedation for 20-40 min using a digital system with the international 10-20 array of electrode placement. All EEGs in this study were recorded during both awake and sleep states. Three minutes of hyperventilation and intermittent photic stimulation in wakefulness were performed during each EEG recording session in all patients. The EEG readers were blinded to the clinical details and groupings. Two child neurologists analyzed EEG recordings with the words
The EEG reports chosen for analysis were solely those for which two child neurologists agreed that the EEG findings showed RE. In addition, the dominant region was defined by the localization of spikes in cases where spikes were more frequent and higher in amplitude. The occurrence of spikes in both the awake and sleep states was scored as follows: (1) the number of spikes with bipolar montage; (2) the localization of spikes, especially the term for frontal EEG focus; and (3) the duration of spike activity. The highest number of spikes from each state was used. The number of spikes was greater in sleep stages 1 and 2 than in the awake state. Accordingly, the rates of discharges were computed in sleep stages 1 and 2 and expressed as the number of discharges per minute. In addition, the presence of spikes in the awake state was also evaluated. These evaluations were made by visual inspection. The spikes were quantified by the same EEG readers. Moreover, EEG readers quantified the spikes in the same EEG recording at least twice, and confirmed the data as intra-rater and inter-rater reliabilities. EEG recordings were started within 8-14 days after the patients' first seizures in all patients. Accordingly, EEG recordings were obtained in the recurrence group before CBZ treatment. All patients were evaluated longitudinally, clinically and by EEG. Repeated EEG recordings were obtained for all patients every 3 months. EEG follow-up was performed for at least 4 years for all patients, and all patients were re-evaluated at the end of follow-up. All EEG recordings from all patients in both groups were analyzed.
Seizure frequency and type
Clinical profiles such as seizure frequency and type were evaluated. All patients were reviewed, and the results were unanimously agreed by all authors. Clinical follow-up for at least 4 years was performed for all patients, and all patients were reevaluated at the end of follow-up.
The neuropsychological evaluations
The Wechsler Intelligence Scale for Children version III (WISC-III) or the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) was evaluated by age in all patients at the onset of seizures and every year.
Statistical methods
Statistical analysis was done using SPSS, version 19 (IBM, New York, NY, USA). All data are presented as means of each measure. Comparisons between the two groups of patients were performed using Fisher's exact test, repeated ANOVA, Dunnett's test, and Student's t-test, as appropriate. A p-value < 0.05 was defined as significant.
Ethics committee and informed consent
Approval from our local ethics committee was obtained for this research. Written, informed consent was obtained from the parents of each patient following a full explanation of the procedures to be performed.
Results
Mean follow-up durations of the recurrence and isolated groups were 4.8 years and 4.3 years, respectively. Clinical profiles of the isolated and recurrence groups are summarized in Table 1 . No children had either developmental delay or focal neurological deficits. In this series of patients, there were no differences in age at seizure onset, developmental and previous febrile seizure (FS) history, family history of epilepsy, or laterality of spike foci between the two groups. Only family history of FS tended to be higher in the recurrence group, but not significantly (p = 0.62). Antiepileptic treatment was administered to children in the recurrence group. The mean interval between the first and third seizure in the recurrence group was 3.9 months. In nine patients in the recurrence group, seizures disappeared 3 weeks after the onset of therapy. In one patient in the recurrence group, seizures disappeared 7 weeks after the onset of therapy. In addition, no oromotor symptoms were observed in the recurrence and isolated groups. Moreover, cognitive decline or behavioral problems such as hyperactivity and impulsiveness were not seen in both groups.
Serial changes of spike frequency were less in the awake state than in the sleep state. Accordingly, the number of spikes was evaluated mainly in the sleep state, and only the presence of spikes was evaluated in the awake state. In sleep stages 1-2, the appearance of spikes in the recurrence group patients was initially 28 times/min on average. In contrast, the average rate of spikes in the isolated group patients was initially 22 times/min. Interictal EEG abnormalities clearly increased during the first year in the recurrence group. Spike rates increased from 28/min to 63/min. In contrast, interictal EEG abnormalities increased slightly during the first 6 months in the isolated group. Spike rates increased from 22/min to 27/min (Fig. 1) . In the recurrence group, spike rates were significantly increased between 6 and 27 months after onset (Dunnett's test; p < 0.01 vs. baseline). In contrast, in the isolated group, spike rates increased significantly only 6 months after onset (Dunnett's test; p < 0.01 vs. baseline). In the recurrence group, a high frequency of paroxysmal EEG abnormalities persisted longer than in the isolated group. Finally, the spike rates for the whole follow-up period were significantly higher in the recurrence group than in the isolated group (repeated ANOVA; p < 0.001).
The appearance of rolandic spikes in the awake recordings differed between the recurrence and isolated groups. The appearance rates in the recurrence and isolated groups were 30% (3/10) and 8.3% (1/12), respectively ( Table 2 ). The appearance of rolandic spikes in awake recordings tended to be more prevalent in the recurrence group than in the isolated group (odds ratio: 4.714, confidence interval: 0.405-548.28). The highest number of spikes per minute in the awake state in the recurrence and isolated groups was 4.3 (mean of three patients) and 4, respectively. All four patients with spikes had the same frequency. In addition, no patients in both groups had frontal EEG foci at seizure onset. However, serial EEGs showed that the EEG focus was in the frontal region (frontal EEG focus having a separate frontal negative spike) in 70% (7/10) of the recurrence group and 16.7% (2/12) of the isolated group, with mean durations of 4.3 months and 4.5 months, respectively. The EEG focus was present in the frontal region significantly more often in the recurrence group than in the isolated group (Fisher's exact test; p < 0.03), but showed no significant difference in duration (Student's t-test; p = 0.88). Atypical EEG manifestations, such as electrical status epilepticus during slow sleep (ESES), were never present during the follow-up period in both groups.
Cognitive function of recurrence group participants was within the normal range (mean full IQ, 98 at onset; 99 at final evaluation). Similarly, cognitive function of isolated group participants was within the normal range (mean full IQ, 97 at onset; 95 at final evaluation). In addition, serial changes of the mean full IQ on the WISC-III or WPPSI were not different between the recurrence group and the isolated group. Accordingly, no patients showed any neuropsychological problems during the follow-up period in both groups.
Anti-epileptic drugs such as CBZ can induce EEG deterioration. However, EEG abnormalities seen in this study never showed frequent widespread bilateral synchronous discharges. In addition, spike rates increased from 27/min to 66/min in the one patient treated by VPA. The spike frequency did not decrease in the patient treated by VPA, similar to patients treated by CBZ. The possibility of results being affected by CBZ in other cases could not be totally ruled out, however, the effect of CBZ cannot account for the worsening of the EEG in this study.
Discussion
The present study showed that seizure recurrence and extended periods of high-frequency paroxysmal EEG abnormalities (>6 months after onset) were significantly correlated in patients with RE. Moreover, the appearance of RD in awake recordings tended to be more prevalent in the recurrence group than in the isolated group. The 22 participants in this study started with typical clinical and EEG features of RE. In addition, the 10 patients in the recurrence group never transitioned to more serious seizure manifestations, such as atypical absences, negative myoclonus, and diurnal seizures with impairments in cognitive functions and behavior that harmed their quality of life thereafter. Furthermore, atypical EEG manifestations such as ESES and extended frontal EEG focus were never present during the follow-up period in both groups.
With regard to the frequency of interictal epileptiform activity and the correlation with atypical manifestations such as more serious seizure manifestations and cognitive/behavioral impairments, the association of more frequent discharges or multifocal paroxysms with complicated evolution in RE is a debated subject. 7 Extreme discrepancies between the rarity of seizures and the activity of the EEG foci are not uncommon, and clinical experience indicates that the EEG is often relatively unchanged, even with effective treatment. 12 In contrast, in patients presenting with atypical clinical manifestations such as oromotor deficits, the number of spikes was most numerous during the period of maximal drooling on the one hand, and spike frequency was markedly reduced when drooling disappeared on the other hand. 13 These findings suggest that oromotor deficits such as drooling may be caused by increased interictal spike activity as part of an inhibitory mechanism affecting the functions of the lower motor strip. 14 Thus, clinical manifestations including seizure activity in RE patients may be correlated with increased frequency of interictal spike activity. The present results showed that spike rates were higher in the recurrence group than in the isolated group. Moreover, a high frequency of EEG abnormalities was seen over long periods in the recurrence group. In another study by Verrotti et al., children with atypical RE demonstrated persistent EEG abnormalities compared with typical RE. 15 These findings indicate that seizure activity was accompanied by a marked increase in spike activity, consistent with previous reports. 7, 9, 16 A combination of spike rate and extended periods of high frequency of paroxysmal EEG abnormalities may predict seizure recurrence in RE. Rolandic spike rates increase in drowsiness and in all stages of sleep. In many children, rolandic spikes are found only in the sleep portion. However, the appearance of rolandic spikes recorded during the awake state differed between the recurrence and the isolated groups in the present study. The abundance of awake interictal abnormalities showed a trend toward a higher risk for developing atypical clinical features such as frequent seizures. 9 These findings suggest that the presence of paroxysmal discharges in the awake state may be correlated with seizure recurrence. In addition, Weglage et al. correlated IQ deficits with greater than 6 spikes/min in the awake EEG; children with 5 spikes or less had no deficits. 17 Moreover, Staden et al. found language dysfunction in 13/20 children and correlated this with greater than 10 spikes/min, 18 with improvement after resolution of spikes. 19 Thus, the presence of paroxysmal discharges in the awake state combined with a high frequency of spikes may be correlated with atypical evolution for RE. In contrast, the present study showed that WISC-III and WPPSI scores were not different between the group with recurrent seizures and that with isolated seizures, though spikes were frequently seen during the awake state in the recurrent seizure group. The patients in the recurrence group showed spikes during the awake state, with 5 spikes or less. This may be the reason why cognitive deficits were not seen in the recurrent seizure group, in agreement with the findings by Weglage et al. 17 Accordingly, as a matter of course, EEGs should be evaluated both in the awake and sleep states. However, a marked interindividual variability from one child to another and from one day to another has been shown. 7 Further investigation will be needed to clarify this point.
CBZ sometimes exacerbates EEG abnormalities and behavioral/ cognitive impairment. However, patients in the recurrence group did not show behavioral/cognitive impairments. In addition, the frequency of paroxysmal EEG abnormalities decreased without discontinuation of CBZ in the recurrence group. Moreover, the spike frequency in the patient treated by VPA increased in a similar manner to that seen in the patients treated by CBZ. Although the effect of CBZ could not be excluded, the effect of CBZ does not account for the worsening EEG in our recurrent cases.
Extended periods of frontal EEG focus suggested a higher risk for developing atypical clinical features in our previous study. 9 However, there was no difference in the periods of frontal EEG focus between the recurrence and isolated groups in the present study. Neither group showed cognitive/behavioral impairments. This might be the reason why there was no difference with the periods of frontal EEG focus. Otherwise, these findings suggest that extended periods of frontal EEG focus affect mainly cognitive/ behavioral disturbance, not mainly seizure recurrence. However, the occurrence of an EEG focus in the frontal region was significantly higher in the recurrence group than in the isolated group in this study. In our previous study, the presence of a frontal paroxysmal EEG abnormality was found to be correlated with subsequent development of epilepsy in FS. 20 These findings suggest that a frontal EEG focus may be associated with seizure recurrence in RE. However, the pathophysiology of a frontal EEG focus remains unclear. Further investigation will be needed to clarify this point. Spike activity such as high frequency may be related to maturation, which is different between the two groups. 21 Similarly, the present study suggests that a high frequency of paroxysmal discharges may be related to seizure recurrence. With a thorough assessment of seizure recurrence and serial EEG recordings from the onset of RE, potential predictors or risk factors for seizure recurrence were identified. However, the present study had some limitations such as its small sample size. The assumptions have to be examined by a careful prospective study of a large population of RE patients.
Conclusion
The present study showed that the presence of extended periods of a high frequency of paroxysmal EEG abnormalities (more than 6 months after onset) and an abundance of awake interictal abnormalities were associated with seizure recurrence. Serially recorded EEG markers may predict recurrent/isolated seizures in children with RE.
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